SciHub
文献互助
期刊查询
一搜即达
科研导航
交流社区
即时热点
登录
注册
发布
文献
求助
首页
我的求助
捐赠本站
清晨好,您是今天最早来到科研通的研友!由于当前在线用户较少,发布求助请尽量完整的填写文献信息,科研通机器人24小时在线,伴您科研之路漫漫前行!
zzerato
Lv3
320 积分
2024-03-06 加入
最近求助
最近应助
互助留言
Gastric Cancer - Epidemiology, Modifiable and Non-modifiable Risk Factors, Challenges and Opportunities: An Updated Review
13小时前
求助中
EUROCARE-4. Survival of cancer patients diagnosed in 1995–1999. Results and commentary
16小时前
已完结
Pembrolizumab plus trastuzumab and chemotherapy for HER2-positive gastric or gastro-oesophageal junction adenocarcinoma: interim analyses from the phase 3 KEYNOTE-811 randomised placebo-controlled trial
18小时前
已完结
Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial
18小时前
已完结
Current developments in gastric cancer: from molecular profiling to treatment strategy
13天前
已完结
Gastric Cancer, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology
14天前
已完结
Cancer incidence and mortality patterns in Europe: Estimates for 40 countries and 25 major cancers in 2018
14天前
已完结
HER2 在 尿路上皮癌中的表达及治疗价值
1个月前
已完结
First-line ribociclib plus letrozole in postmenopausal women with HR+ , HER2− advanced breast cancer: Tumor response and pain reduction in the phase 3 MONALEESA-2 trial
2个月前
已完结
Time to Second Objective Disease Progression (PFS2): An Emerging Clinical Trial Endpoint with Regulatory and Reimbursement Implications
2个月前
已完结
没有进行任何应助
速度真快
2个月前
需要的是该文献的补充材料,不是该篇文献
7个月前
最近帖子
最近评论
没有发布任何帖子
没有发布任何评论